We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

Molecular Imaging Technique Improves Endometriosis Diagnosis

By MedImaging International staff writers
Posted on 08 Jun 2022
Print article
Image: 99mTc-maraciclatide planar imaging has the capacity to image the whole body (Photo courtesy of Serac Healthcare)
Image: 99mTc-maraciclatide planar imaging has the capacity to image the whole body (Photo courtesy of Serac Healthcare)

Endometriosis is a common inflammatory condition affecting women, associated with painful periods, chronic pelvic pain, and infertility. It is believed to be due to tissue that resembles the lining of the womb sticking to areas outside the uterus, usually in the pelvis. However, diagnosing endometriosis often results in multiple visits to physicians, multiple scans and often surgery to confirm the diagnosis. As a result, there is a delay to get a diagnosis of endometriosis, mainly due to lack of non-invasive tests capable of detecting all endometriosis subtypes (ovarian, superficial, and deep disease). Now, a new research study is investigating whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Endometriosis experts at the University of Oxford (Oxford, UK) have joined hands with Serac Healthcare Ltd. (London, UK) to investigate whether an experimental imaging marker (⁹⁹ᵐTc maraciclatide) that binds to areas of inflammation can be used in endometriosis to visualize the disease on a scan. The imaging marker has been used for detecting inflammation in conditions such as rheumatoid arthritis in other research studies across the UK, EU and US. Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.

The potential strengths of the scan lie in the way the imaging marker binds to areas of inflammation, which may allow doctors to distinguish between new and old lesions and detect endometriosis in areas not easily seen during surgery such as the lung. The development of a 20-minute imaging test would reduce the need for repeated visits to doctors, for repeated investigations, and for invasive surgery to obtain a diagnosis. This would ultimately reduce the time taken to confirm or exclude endometriosis.

Initially, the study will involve women who are scheduled to have planned surgery for suspected endometriosis. Two to seven days before their operation, the participants will be invited for an imaging scan which will compare the suspected locations of disease detected on the scan and in surgery to confirm whether this imaging test could be an effective non-invasive method of detecting all endometriosis subtypes.

“There is an urgent unmet clinical need for a non-invasive marker to identify or rule out endometriosis as it is such a very common disease affecting more than 190 million women worldwide,” said Professor Christian Becker, Co-Director of the Endometriosis CaRe Centre in Oxford, who will lead the study.

“We are excited about the potential of ⁹⁹ᵐTc maraciclatide to diagnose endometriosis non-invasively and delighted to be working with the internationally renowned team at Oxford on this important first study,” said David Hail, CEO of Serac Healthcare.

Related Links:
University of Oxford 
Serac Healthcare Ltd. 


Print article
CIRS -  MIRION
Radcal

Channels

MRI

view channel
Image: Hyperpolarized MRI technology reveals changes in heart muscle’s sugar metabolism after heart attack (Photo courtesy of ETH Zurich)

MRI Technology to Visualize Metabolic Processes in Real Time Could Improve Heart Disease Diagnosis

Magnetic resonance imaging (MRI) has become an indispensable part of medicine. It allows unique insights into the body and diagnosis of various diseases. However, current MRI technology has its limitations:... Read more

Ultrasound

view channel
Image: A combination of ultrasound and nanobubbles allows cancerous tumors to be destroyed without surgery (Photo courtesy of Tel Aviv University)

Ultrasound Combined With Nanobubbles Enables Removal of Tumors Without Surgery

The prevalent method of cancer treatment is surgical removal of the tumor, in combination with complementary treatments such as chemotherapy and immunotherapy. Therapeutic ultrasound to destroy the cancerous... Read more

General/Advanced Imaging

view channel
Image: AI tool predicts reduced blood flow to the heart (Photo courtesy of Pexels)

AI Tool Uses CT Scans to Identify Patients at Risk of Reduced Blood Flow to the Heart

Blockages of the coronary arteries typically occur due to the buildup of fatty plaques. This may restrict blood flow to the heart, causing chest pain, heart attacks, or even death. Identifying which arteries... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.